193 related articles for article (PubMed ID: 33216652)
1. Tuberculosis-Related Uveitis in Patients under Anti-TNF-alpha Therapy: A Case Series.
Hernanz I; Miguel Escuder L; Chamorro L; Moll-Udina A; Espinosa G; Sainz de la Maza M; Llorenç V; Adán A
Ocul Immunol Inflamm; 2022 May; 30(4):839-844. PubMed ID: 33216652
[TBL] [Abstract][Full Text] [Related]
2. Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab.
Ucan Gunduz G; Yalcinbayir O; Cekic S; Yildiz M; Kilic SS
J Ocul Pharmacol Ther; 2021 May; 37(4):236-240. PubMed ID: 33512278
[No Abstract] [Full Text] [Related]
3. Primary tuberculosis infection in patients treated with tumor necrosis factor-alpha antagonists and a negative initial screening.
Bernal JA; Andrés M; Jovaní V; García Sevila R; Begazo A; Vela P
Reumatol Clin; 2016; 12(2):81-4. PubMed ID: 26099453
[TBL] [Abstract][Full Text] [Related]
4. Miliary tuberculosis developing during adalimumab treatment for Behçet's disease with uveitis.
Kim MJ; Jones N; Steeples LR
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567192
[TBL] [Abstract][Full Text] [Related]
5. Uveitis occurrence in patients with ankylosing spondylitis according to the type of tumour necrosis factor inhibitor: a cohort study of 175 patients.
Choi EY; Lee M; Lee CS
Clin Exp Rheumatol; 2020; 38(6):1132-1137. PubMed ID: 32828140
[TBL] [Abstract][Full Text] [Related]
6. Incidences of serious infections and tuberculosis among patients receiving anti-tumor necrosis factor-α therapy.
Yoo IK; Choung RS; Hyun JJ; Kim SY; Jung SW; Koo JS; Lee SW; Choi JH; Kim H; Lee HS; Keum B; Kim ES; Jeen YT
Yonsei Med J; 2014 Mar; 55(2):442-8. PubMed ID: 24532516
[TBL] [Abstract][Full Text] [Related]
7. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.
Kim ES; Song GA; Cho KB; Park KS; Kim KO; Jang BI; Kim EY; Jeon SW; Lee HS; Yang CH; Lee YK; Lee DW; Kim SK; Kim TO; Lee J; Kim HW; Jee SR; Park SJ; Kim HJ
World J Gastroenterol; 2015 Mar; 21(11):3308-16. PubMed ID: 25805938
[TBL] [Abstract][Full Text] [Related]
8. Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis.
Thng ZX; Regenold J; Bromeo AJ; Akhavanrezayat A; Than NTT; Khatri A; Mohammadi SS; Tran ANT; Shin YU; Karaca I; Ghoraba HH; Or CCM; Nguyen QD
Expert Opin Investig Drugs; 2024 Feb; 33(2):95-104. PubMed ID: 38299551
[TBL] [Abstract][Full Text] [Related]
9. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.
Cantini F; Lubrano E; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
Int J Rheum Dis; 2016 Aug; 19(8):799-805. PubMed ID: 26172207
[TBL] [Abstract][Full Text] [Related]
10. Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients.
Maalouf G; Andrillon A; Leclercq M; Sève P; Bielefeld P; Gueudry J; Sené T; Titah C; Moulinet T; Rouvière B; Sène D; Desbois AC; Domont F; Touhami S; Thibault T; Chamieh CE; Cacoub P; Kodjikian L; Biard L; Bodaghi B; Saadoun D
Am J Ophthalmol; 2022 Jun; 238():173-180. PubMed ID: 35172172
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of latent tuberculosis treatment for immunocompetent uveitis patients with a positive T-SPOT.TB test: 6-year experience in a tuberculosis endemic region.
Chung CY; Li KKW
Int Ophthalmol; 2018 Dec; 38(6):2273-2282. PubMed ID: 28948453
[TBL] [Abstract][Full Text] [Related]
12. Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment.
Park DI; Hisamatsu T; Chen M; Ng SC; Ooi CJ; Wei SC; Banerjee R; Hilmi IN; Jeen YT; Han DS; Kim HJ; Ran Z; Wu K; Qian J; Hu PJ; Matsuoka K; Andoh A; Suzuki Y; Sugano K; Watanabe M; Hibi T; Puri AS; Yang SK
J Gastroenterol Hepatol; 2018 Jan; 33(1):20-29. PubMed ID: 29023903
[TBL] [Abstract][Full Text] [Related]
13. TNF inhibition for ophthalmic indications: current status and outlook.
Rifkin LM; Birnbaum AD; Goldstein DA
BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
[TBL] [Abstract][Full Text] [Related]
14. The T-SPOT.TB assay used for screening and monitoring of latent tuberculosis infection in patients with Behçet's disease pre- and post-anti-TNF treatment: A retrospective study.
Shen Y; Ma HF; Luo D; Guan JL
J Chin Med Assoc; 2019 May; 82(5):375-380. PubMed ID: 30896580
[TBL] [Abstract][Full Text] [Related]
15. Presumed tuberculous uveitis: diagnosis, management, and outcome.
Sanghvi C; Bell C; Woodhead M; Hardy C; Jones N
Eye (Lond); 2011 Apr; 25(4):475-80. PubMed ID: 21293496
[TBL] [Abstract][Full Text] [Related]
16. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists.
Lou SM; Larkin KL; Winthrop K; Rosenbaum JT;
Ocul Immunol Inflamm; 2015 Feb; 23(1):25-31. PubMed ID: 25019973
[TBL] [Abstract][Full Text] [Related]
17. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
[TBL] [Abstract][Full Text] [Related]
18. Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users.
Al-Fadel N; Almutairi A; Aldhirgham T; Abuesba L; Alrwisan A; Alharbi F
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5682. PubMed ID: 37615200
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced Sarcoid Uveitis with Biologics.
Sobolewska B; Baglivo E; Edwards AO; Kramer M; Miserocchi E; Palestine AG; Schwab IR; Zamir E; Doycheva D; Zierhut M
Ocul Immunol Inflamm; 2022 May; 30(4):907-914. PubMed ID: 33596386
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNFα agents and methotrexate in spondyloarthritis related uveitis in a Chinese population.
Lian F; Zhou J; Wei C; Wang Y; Xu H; Liang L; Yang X
Clin Rheumatol; 2015 Nov; 34(11):1913-20. PubMed ID: 26070537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
